Interested in Oriola as an investment?

Oriola operates in the Finnish and Swedish health and wellbeing markets

Oriola serves the health and wellbeing market with modern and customer-focused products and services, and connects all actors within the field, from pharmaceutical companies to pharmacies and consumers.

Financial statements release 2022

Oriola Corporation will publish its financial statements release 1 January–31 December 2022 on Thursday, 16 February 2023 approximately at 8.30 a.m. (EET). Welcome to join a live-webcast on 10 a.m. (EET) on the same day.

Join the webcast See the invitation

Oriola as an investment

Oriola has long experience and a strong position in the Finnish and Swedish pharmaceutical markets. Our wide range of services help pharmaceutical companies, pharmacies and other operators in the healthcare sector to succeed and promote a healthier life for people.

Why invest in Oriola

Shortcut to investor tools

Key figures Share information Shareholders

Latest stock exchange releases

30.01.2023 | Stock exchange releases

Oriola Corporation records EUR 9.8 million write-downs of other tangible and intangible assets and provides preliminary information on its year 2022 financial performance

12.01.2023 | Stock exchange releases

Proposals of the Shareholders’ Nomination Board of Oriola Corporation concerning the Board of Directors to be elected by the 2023 Annual General Meeting

24.11.2022 | Stock exchange releases

Change in Oriola Management Team

See all stock exchange releases from our newsroom Subscribe to releases

Looking for financial reports or other financial information?

Reports and presentations Financial information Investor calendar Investor contacts

Investment for health and wellbeing